Mark A. Breidenbach, Ph.D. - Publications

2005 Stanford University, Palo Alto, CA 
crystallography, synaptic neurotransmission

10/13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Sogi KM, Gartner ZJ, Breidenbach MA, Appel MJ, Schelle MW, Bertozzi CR. Mycobacterium tuberculosis Rv3406 is a type II alkyl sulfatase capable of sulfate scavenging. Plos One. 8: e65080. PMID 23762287 DOI: 10.1371/Journal.Pone.0065080  0.92
2012 Breidenbach MA, Palaniappan KK, Pitcher AA, Bertozzi CR. Mapping yeast N-glycosites with isotopically recoded glycans. Molecular & Cellular Proteomics : McP. 11: M111.015339. PMID 22261724 DOI: 10.1074/Mcp.M111.015339  0.92
2010 Breidenbach MA, Gallagher JE, King DS, Smart BP, Wu P, Bertozzi CR. Targeted metabolic labeling of yeast N-glycans with unnatural sugars. Proceedings of the National Academy of Sciences of the United States of America. 107: 3988-93. PMID 20142501 DOI: 10.1073/Pnas.0911247107  0.92
2009 Brunger AT, Jin R, Breidenbach MA. Interactions Between Botulinum Neurotoxins and Synaptic Vesicle Proteins Botulinum Toxin: Therapeutic Clinical Practice and Science. 41-54. DOI: 10.1016/B978-1-4160-4928-9.00004-4  0.92
2008 Brunger AT, Jin R, Breidenbach MA. Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins. Cellular and Molecular Life Sciences : Cmls. 65: 2296-306. PMID 18425411 DOI: 10.1007/S00018-008-8088-0  0.92
2008 Carlson BL, Ballister ER, Skordalakes E, King DS, Breidenbach MA, Gilmore SA, Berger JM, Bertozzi CR. Function and structure of a prokaryotic formylglycine-generating enzyme. The Journal of Biological Chemistry. 283: 20117-25. PMID 18390551 DOI: 10.1074/Jbc.M800217200  0.92
2007 Brunger AT, Breidenbach MA, Jin R, Fischer A, Santos JS, Montal M. Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain. Plos Pathogens. 3: 1191-4. PMID 17907800 DOI: 10.1371/Journal.Ppat.0030113  0.92
2005 Breidenbach MA, Brunger AT. New insights into clostridial neurotoxin-SNARE interactions. Trends in Molecular Medicine. 11: 377-81. PMID 16006188 DOI: 10.1016/J.Molmed.2005.06.012  0.92
2005 Breidenbach MA, Brunger AT. 2.3 A crystal structure of tetanus neurotoxin light chain. Biochemistry. 44: 7450-7. PMID 15895988 DOI: 10.1021/Bi050262J  0.92
2004 Breidenbach MA, Brunger AT. Substrate recognition strategy for botulinum neurotoxin serotype A. Nature. 432: 925-9. PMID 15592454 DOI: 10.1038/Nature03123  0.92
Low-probability matches
2013 Breidenbach M. SAS, refined Nature Structural & Molecular Biology. 20: 775-775. DOI: 10.1038/nsmb.2634  0.01
1998 Fournet A, Inchausti A, Yaluff G, Rojas De Arias A, Guinaudeau H, Bruneton J, Breidenbach MA, Karplus PA, Faerman CH. Trypanocidal bisbenzylisoquinoline alkaloids are inhibitors of trypanothione reductase. Journal of Enzyme Inhibition. 13: 1-9. PMID 9879510  0.01
1996 Faerman CH, Savvides SN, Strickland C, Breidenbach MA, Ponasik JA, Ganem B, Ripoll D, Krauth-Siegel RL, Karplus PA. Charge is the major discriminating factor for glutathione reductase versus trypanothione reductase inhibitors. Bioorganic & Medicinal Chemistry. 4: 1247-53. PMID 8879546 DOI: 10.1016/0968-0896(96)00120-4  0.01
Hide low-probability matches.